warnings
Warnings For external use only
Capsimide
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Capsimide
- Generic name
- CAPSAICIN 0.025% TOPICAL PATCH
- Manufacturer
- Sola Pharmaceuticals
- Product type
- HUMAN OTC DRUG
- SPL set ID
- e81c2de8-6429-d681-e053-2995a90a36a9
- SPL ID
- 45724ae3-b3d0-638d-e063-6294a90af2da
- Version
- 4
- Effective date
- 2025-12-08
- Source export date
- 2026-09-28
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:26:33
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M017 | openfda.application_number | |
| brand name | Capsimide | openfda.brand_name | |
| generic name | CAPSAICIN 0.025% TOPICAL PATCH | openfda.generic_name | |
| manufacturer name | Sola Pharmaceuticals | openfda.manufacturer_name | |
| ndc | package | 70512-016-10 | openfda.package_ndc |
| ndc | product | 70512-016 | openfda.product_ndc |
| ndc11 | package | 70512001610 | derived:openfda.package_ndc |
| rxcui | 1043399 | openfda.rxcui | |
| spl id | 45724ae3-b3d0-638d-e063-6294a90af2da | id | |
| spl set id | e81c2de8-6429-d681-e053-2995a90a36a9 | set_id | |
| unii | S07O44R1ZM | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.